A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

PHASE2UnknownINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

October 31, 2002

Conditions
Prostatic Hyperplasia
Interventions
DRUG

ML-04A

Trial Locations (14)

11706

RECRUITING

Edward Loizides, MD, Bay Shore

18960

RECRUITING

Richard Landau, MD, Sellersville

20850

RECRUITING

Gary Friedlander, MD, Rockville

23249

RECRUITING

Michael Godschalk, MD, Richmond

33761

RECRUITING

Donald Bergner, MD, Clearwater

34474

RECRUITING

Ira Klimberg, MD, Ocala

36608

RECRUITING

Charles White, MD, Mobile

73104

RECRUITING

H. Pat Hezmall, MD, Fort Worth

80012

RECRUITING

Joel Kaufman, MD, Aurora

89109

RECRUITING

Sheldon Freedman, MD, Las Vegas

91405

RECRUITING

Eugene Dula, MD, Van Nuys

94305

RECRUITING

Rodney Anderson, MD, Stanford

95628

RECRUITING

Douglas Young, MD, Fair Oaks

99202

RECRUITING

Roger Fincher, MD, Spokane

Sponsors
All Listed Sponsors
lead

Milkhaus Laboratory

INDUSTRY

NCT00044226 - A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH). | Biotech Hunter | Biotech Hunter